Guidance

UK Health Security Agency (UKHSA) PGD Templates

14 September 2020Patient Group Direction templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.

Patient Group Directions (PGDs) and abortifacients

14 September 2020This article advises on the legal position on the supply/administration of abortifacients under PGDs.

Auditing Patient Group Directions

14 September 2020SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.

Registration required

Paclitaxel: Cytotoxic Drug Stability Monograph

10 September 2020Stability information is essential for the safe aseptic preparation of paclitaxel

Registration required

Mitoxantrone: Cytotoxic Drug Stability Monograph

10 September 2020Stability information is essential for the safe aseptic preparation of mitoxantrone

Labelling medicines supplied without a prescription

9 September 2020Advice on the legal labelling requirements for Prescription Only Medicines and Pharmacy Medicines supplied under a patient group direction or legal exemption.

Inclusion of dose ranges in a single Patient Group Direction

9 September 2020The below summarises the considerations required if a single PGD is to include a range of doses.

Mixing of medicines and Patient Group Directions

9 September 2020This article provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD

Managing Patient Group Directions following amendments or changes

8 September 2020There are requirements for all PGDs to be resigned or reauthorised after any amendment or change made during its valid to/from dates

Use of PGDs by trainee registered healthcare professionals

8 September 2020Advice on the use of Patient Group Directions by registered healthcare professionals who are undertaking training and/or competency assessment

SPS - Specialist Pharmacy Service

NHS